New drug shows promise in reducing COPD symptoms in smokers, clinical trials show
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Tue, 8 September 2026
What it is about
Tom WernerFrank SciurbaAstrazenecaCenters For DiseaseAmerican Lung AssociationDrug AdministrationEuropean Respiratory Society CongressUniversity Of PittsburghAmerican
Who published it, and when
How it spread - 1 original report
Tue, 8 September 2026
1 report- hitsfm.net19:15first to report
A healthcare professional examines a chest X-ray displayed on a tablet. (Getty Images/Tom Werner)(NEW YORK) -- A new drug appeared to show promise in reducing rates of chronic obstructive pulmonary disease (COPD) symptoms in former and current smokers, according to results from late-stage clinical trials.The medication, called tozorakimab and developed by AstraZeneca, is the first biologic drug to show efficacy in treating COPD symptoms, according to Dr. Frank Sciurba, professor of Pulmonary...